跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Resveratrol/Curcumin
首页
药物
Resveratrol/Curcumin
Resveratrol/Curcumin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
FLAVONOID POLYPHENOL DRUG SELF-EMULSIFYING COMPOSITION, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND APPLICATION THEREOF
EP 3954380 A4
申请人: BEIJING WEHAND BIO PHARMACEUTICAL CO LTD
优先权: 2019
CN
EP
US
WO
6 件公开
COMPOSITIONS AND METHODS FOR ALLEVIATING CONDITIONS CAUSED BY ABNORMAL SUBCUTANEOUS DEPOSIT OF ADIPOSE TISSUE OR FAT
EP 4525839 A1
申请人: CALIWAY BIOPHARMACEUTICALS CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
Bioactive supplement
US 12605357 B2
申请人: SILVA WELLINGTON
优先权: 2020
EP
US
WO
4 件公开
Antioxidative stress compositions, methods of preparing and uses thereof
US 10413524 B2
申请人: PEZZUTO JOHN MICHAEL
优先权: 2018
US
4 件公开
Cannabigerol (CBG) products and methods of use
US 11890311 B1
申请人: BAZELET HEALTH SYSTEMS INC
优先权: 2022
US
4 件公开
CURCUMIN AND RESVERATROL FOR CHRONIC INFLAMMATION
EP 3386492 A1
申请人: DSM IP ASSETS BV
优先权: 2015
CN
EP
US
3 件公开
COMPOSITION FOR REDUCING LOCAL FAT AND BODY WEIGHT, AND PHARMACEUTICALS AND USE THEREOF
EP 3811935 A1
申请人: CALIWAY BIOPHARMACEUTICALS CO LTD
优先权: 2014
CN
EP
3 件公开
COMPOSITIONS FOR ENHANCING SPORTS PERFORMANCE
EP 3795150 A1
申请人: NEKTIUM PHARMA S L
优先权: 2016
EP
US
3 件公开
COMBINATION THERAPY COMPRISING PLANT DERIVED COMPOUNDS AND ANTINEOPLASTIC COMPOUNDS FOR TREATMENT OF HEMATOLOGICAL MALIGNANCIES
EP 3861992 C0
申请人: CANNAFAMILY A S
优先权: 2020
EP
US
3 件公开
COMPOSITION OF THE PHYTOCOMPOUNDS INTENDED TO ENHANCE CYTOTOXIC ACTIVITY IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
US 2024165074 A1
申请人: GDANSKI UNIV MEDYCZNY
优先权: 2021
US
WO
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈